Global Meperidine Market, Size, Trends, By Product Type (Powder and Liquid) and By Application (Anesthesia, Cough Treatment, and Diarrhea Treatment), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Meperidine Market
The Global Meperidine Market was valued at US$ 493.6 Mn in 2022, estimated to reach US$ 523.6 Mn by 2030, with a CAGR of 0.74% from 2023-2030.
An opioid painkiller is a meperidine. Narcotics is another name for an opioid. Meperidine reduces pain by influencing the central nervous system (CNS). Given that it has a lower risk of addiction and is safer than morphine, many doctors prefer to prescribe meperidine for the treatment of acute and chronic severe pain. Meperidine shouldn't be applied to chronic or recurrent pain. Only abrupt episodes of moderate to severe pain should be treated with it. Only a restricted distribution program known as the Opioid Analgesic REMS (Risk Evaluation and Mitigation Strategy) program allows access to this medication. Demerol and Pethidine are two of the various brand names for meperidine. Demerol is available as a pill or a liquid.
Market Drivers
The market is being driven by the rising prevalence of conditions like cancer, periodontal disease, post-surgical pain, lower back pain, fibromyalgia, and arthritis that result in chronic pain. According to the "Postoperative Pain Control" study, around 75% of patients who have surgery have acute postoperative pain, which is frequently of medium-high severity and contributes to the total increase.
An important market trend is a considerable increase in the elderly population, which follows a growth in the need for pain treatment products. The popularity of medications containing meperidine is likely to increase as a result of this trend. The cost-effectiveness of over-the-counter analgesics, technical advancements in drug delivery methods, and rising patient awareness are driving up demand for meperidine medications.
Market Restraints
Meperidine abuse, dependency, and side effects of drugs may restrict the market the growth during the forecast period. The emergence and legalization of alternative treatments of opioids such as cannabis impede the growth of the market.
Market Segmentation
The scope of the Global Meperidine Market covers segmentation based on Product Type, Application, and Region.
Based on Product Type, the market is segmented into Powder and Liquid.
Based on Application, the market is divided into Anesthesia, Cough Treatment, and Diarrhea Treatment.
Regional Analysis
The Global Meperidine Market is segmented into 5 main regions, namely, North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America maintained the largest market share due to the enormous number of surgeries carried out in the U.S. Among the reasons propelling the market in this area are the rising incidence of pain and pain-related diseases as well as the rising prevalence of chronic disorders. The cost of healthcare has increased for the region's countries as a result of this. The number of patients is gradually rising, and product awareness and adoption are rising, which is propelling market expansion in the area.
Over the projection period, the Asia-Pacific region is anticipated to experience the quickest growth. The expansion is linked to an increase in the number of dental and aesthetic treatments, technological developments in surgery, and rising meperidine usage for postoperative pain control.
Key Players
Purdue Pharma, Egalet Corporation, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., Actavis PLC, and Pfizer, Inc.
Market Taxonomy
By Product Type
• Powder
• Liquid
By Application
• Anesthesia
• Cough Treatment
• Diarrhea Treatment
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Meperidine Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Meperidine Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Meperidine Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Meperidine Market Share Analysis, By Product Type
5.3 Global Meperidine Market Size and Forecast, By Product Type
5.3.1 Powder
5.3.2 Liquid
6 Global Meperidine Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Meperidine Market Share Analysis, By Application
6.3 Global Meperidine Market Size and Forecast, By Application
6.3.1 Anesthesia
6.3.2 Cough Treatment
6.3.3 Diarrhea Treatment
7 Global Meperidine Market, By Region
7.1 Global Meperidine Market Share Analysis, By Region
7.2 Global Meperidine Market Size and Forecast, By Region
7.3 Global Meperidine Market Trends and Forecast, By Region
8 North America Meperidine Market Analysis and Forecast (2023-2030)
8.1 Introduction
8.2 North America Meperidine Market Share Analysis, By Product Type
8.3 North America Meperidine Market Size and Forecast, By Application
8.5 North America Meperidine Market Size and Forecast, By Country
8.5.1 U.S.
8.5.1.1 Market Size and Forecast, By Product Type
8.5.1.2 Market Size and Forecast, By Application
8.5.2 Canada
8.5.2.1 Market Size and Forecast, By Product Type
8.5.2.2 Market Size and Forecast, By Application
8.5.3 Mexico
8.5.3.1 Market Size and Forecast, By Product Type
8.5.3.2 Market Size and Forecast, By Application
9 Europe Meperidine Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 Europe Meperidine Market Share Analysis, By Product Type
9.3 Europe Meperidine Market Size and Forecast, By Application
9.5 Europe Meperidine Market Size and Forecast, By Country
9.5.1 Germany
9.5.1.1 Market Size and Forecast, By Product Type
9.5.1.2 Market Size and Forecast, By Application
9.5.2 France
9.5.2.1 Market Size and Forecast, By Product Type
9.5.2.2 Market Size and Forecast, By Application
9.5.3 UK
9.5.3.1 Market Size and Forecast, By Product Type
9.5.3.2 Market Size and Forecast, By Application
9.5.4. Russia
9.5.4.1 Market Size and Forecast, By Product Type
9.5.4.2 Market Size and Forecast, By Application
9.5.5. Italy
9.5.5.1 Market Size and Forecast, By Product Type
9.5.5.2 Market Size and Forecast, By Application
9.5.6 Spain
9.5.6.1 Market Size and Forecast, By Product Type
9.5.6.2 Market Size and Forecast, By Application
9.5.7 Rest of Europe
9.5.7.1 Market Size and Forecast, By Product Type
9.5.7.2 Market Size and Forecast, By Application
10 Asia Pacific Meperidine Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Asia Pacific Meperidine Market Share Analysis, By Product Type
10.3 Asia Pacific Meperidine Market Size and Forecast, By Application
10.5 Asia Pacific Meperidine Market Size and Forecast, By Country
10.5.1 China
10.5.1.1 Market Size and Forecast, By Product Type
10.5.1.2 Market Size and Forecast, By Application
10.5.2 Japan
10.5.2.1 Market Size and Forecast, By Product Type
10.5.2.2 Market Size and Forecast, By Application
10.5.3 India
10.5.3.1 Market Size and Forecast, By Product Type
10.5.3.2 Market Size and Forecast, By Application
10.5.4. South Korea
10.5.4.1 Market Size and Forecast, By Product Type
10.5.4.2 Market Size and Forecast, By Application
10.5.5. Australia
10.5.5.1 Market Size and Forecast, By Product Type
10.5.5.2 Market Size and Forecast, By Application
10.5.6. New Zealand
10.5.6.1 Market Size and Forecast, By Product Type
10.5.6.2 Market Size and Forecast, By Application
10.5.7 Singapore
10.5.7.1 Market Size and Forecast, By Product Type
10.5.7.2 Market Size and Forecast, By Application
10.5.8. Malaysia
10.5.8.1 Market Size and Forecast, By Product Type
10.5.8.2 Market Size and Forecast, By Application
10.5.9 Rest of Asia
10.5.9.1 Market Size and Forecast, By Product Type
10.5.9.2 Market Size and Forecast, By Application
11 Latin America Meperidine Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Latin America Meperidine Market Share Analysis, By Product Type
11.3 Latin America Meperidine Market Size and Forecast, By Application
11.5 Latin America Meperidine Market Size and Forecast, By Country
11.5.1 Brazil
11.5.1.1 Market Size and Forecast, By Product Type
11.5.1.2 Market Size and Forecast, By Application
11.5.2 Argentina
11.5.2.1 Market Size and Forecast, By Product Type
11.5.2.2 Market Size and Forecast, By Application
11.5.3. Colombia
11.5.3.1 Market Size and Forecast, By Product Type
11.5.3.2 Market Size and Forecast, By Application
11.5.4. Peru
11.5.4.1 Market Size and Forecast, By Product Type
11.5.4.2 Market Size and Forecast, By Application
11.5.5 Chile
11.5.5.1 Market Size and Forecast, By Product Type
11.5.5.2 Market Size and Forecast, By Application
11.5.6 Venezuela
11.5.6.1 Market Size and Forecast, By Product Type
11.5.6.2 Market Size and Forecast, By Application
11.5.7 Rest of Latin America
11.5.7.1 Market Size and Forecast, By Product Type
11.5.7.2 Market Size and Forecast, By Application
12 Middle East Meperidine Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Middle East Meperidine Market Share Analysis, By Product Type
12.3 Middle East Meperidine Market Size and Forecast, By Application
12.5 Middle East Meperidine Market Size and Forecast, By Country
12.5.1 Saudi Arabia
12.5.1.1 Market Size and Forecast, By Product Type
12.5.1.2 Market Size and Forecast, By Application
12.5.2 UAE
12.5.2.1 Market Size and Forecast, By Product Type
12.5.2.2 Market Size and Forecast, By Application
12.5.3 Egypt
12.5.3.1 Market Size and Forecast, By Product Type
12.5.3.2 Market Size and Forecast, By Application
12.5.4 Kuwait
12.5.4.1 Market Size and Forecast, By Product Type
12.5.4.2 Market Size and Forecast, By Application
12.5.5 South Africa
12.5.5.1 Market Size and Forecast, By Product Type
12.5.5.2 Market Size and Forecast, By Application
12.5.5 Rest of Middle East & Africa
12.5.6.1 Market Size and Forecast, By Product Type
12.5.6.2 Market Size and Forecast, By Application
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Purdue Pharma
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Egalet Corporation
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Boehringer Ingelheim
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Sanofi
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Sun Pharmaceuticals
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Mallinckrodt Pharmaceuticals
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Endo Pharmaceuticals Inc.
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Actavis PLC
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Pfizer, Inc.
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
